Showing 3141-3150 of 6035 results for "".
- Altris AI Algorithm for Detection of Retinal Conditions on OCT Scans Receives European CE Mark Approvalhttps://modernod.com/news/altris-ai-algorithm-for-detection-of-retinal-conditions-on-oct-scans-receives-european-ce-mark-approval/2479561/Altris AI announced that it has received the CE Mark approval for its Standard Functionality for retinal conditions detection on Optical Coherence Tomography (OCT) scans. Altris AI Standard Functionality is ready for preliminary screening of retinal diseases in clinical practice. Altris AI detect
- Glaukos Announces Global Licensing Agreement With Intratus, Maker of Noninvasive Drug Delivery Platformhttps://modernod.com/news/glaukos-announces-global-licensing-agreement-with-intratus/2476756/Glaukos announced that it has entered into a licensing agreement with privately held, early-stage life sciences company Intratus. Under terms of the deal, Intratus has granted Glaukos a global exclusive license to
- Novartis Teams Up With Celebrity Interior Designer Nate Berkus To Launch ‘My Home In Sight’https://modernod.com/news/novartis-teams-up-with-celebrity-interior-designer-nate-berkus-to-launch-my-home-in-sight/2476753/Novartis is teaming up with celebrity interior designer Nate Berkus to launch “My Home in Sight,” a program that aims to raise awareness of the daily impact of wet age-related macular degeneration (AMD) and empower those living with wet AMD and their car
- New Age-Related Macular Degeneration Common in Untreated Fellow Eyeshttps://modernod.com/news/new-age-related-macular-degeneration-common-in-untreated-fellow-eyes/2476748/New age-related macular degeneration (AMD) develops in about a quarter of fellow eyes to those treated for neovascular AMD with intravitreal anti-VEGF agents, according to a post hoc analysis of the VIEW 1 and VIEW 2 studies, as reported b
- Double-Barreled Biologic for Diabetic Retinopathy Emerginghttps://modernod.com/news/double-barreled-biologic-for-diabetic-retinopathy-emerging-2/2476749/Investigators searching for new ways to manage diabetic macular edema are targeting pathways beyond vascular endothelial growth factor (VEGF), the only pathway for which there are approved therapies, and are developing treatments that can be administered less often, according to a Medscape
- Medicel Launches First 2-in-1 Lens Injection Systemhttps://modernod.com/news/medicel-launches-first-2-in-1-lens-injection-system/2476740/Medicel says it has launched the world’s first 100% 2-in-1 lens injector, the Accuject Dual. The new injector enables surgeons to operate either in push or screw mode, allowing more control. Unlike competitor dual-mode injectors on the market that are 50% push and 50% screw, the Accuject
- Foundation Fighting Blindness Appoints Judy Taylor Vice President, Developmenthttps://modernod.com/news/foundation-fighting-blindness-appoints-judy-taylor-vice-president-development/2476733/The Foundation Fighting Blindness has announced that it has appointed Judy Taylor as vice president, development. In her new role, Ms. Taylor will be responsible and accountable for the strategic direction, planning and oversight of major gifts and planned giving function for the foundation.
- Ocular Therapeutix Announces Christopher White as Senior Vice President, Head of Business and Corporate Developmenthttps://modernod.com/news/ocular-therapeutix-announces-christopher-white-as-senior-vice-president-head-of-business-and-corporate-development/2476725/Ocular Therapeutix announced the appointment of Christopher White as Senior Vice President, Head of Business and Corporate Development. “We are thrilled to welcome Chris to the Ocular team to oversee business and corporate development,” Antony Mattessich, President and Chief Executive Offi
- Children’s Hospital Los Angeles Has Treated 14 Patients With Retinal Degeneration Using Gene Therapyhttps://modernod.com/news/childrens-hospital-los-angeles-has-treated-14-patients-with-retinal-degeneration-using-gene-therapy/2476727/More than a year after becoming one of the first medical institutions nationally to complete a revolutionary gene replacement surgery to restore vision in patients with retinal degeneration, surgeons at The Vision Center at Children’s Hospital Los Angeles (CHLA) have successfully completed the pr
- Double-Barreled Biologic for Diabetic Retinopathy Emerginghttps://modernod.com/news/double-barreled-biologic-for-diabetic-retinopathy-emerging/2476720/Investigators searching for new ways to manage diabetic macular edema are targeting pathways beyond vascular endothelial growth factor (VEGF), the only pathway for which there are approved therapies, and are developing treatments that can be administered less often, according to a